The purpose of this observational study is to describe the patient, disease and treatment characteristics of eligible participants with upper gastrointestinal cancer treated with adjuvant nivolumab.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Participant sociodemographics
Timeframe: Baseline
Participant Eastern Cooperative Oncology Group (ECOG) score
Timeframe: Baseline
Participant histology results
Timeframe: Baseline
Participant comorbidities
Timeframe: Baseline
Participant tumour location
Timeframe: Baseline
Date of tumour resection
Timeframe: Baseline
Participant primary upper gastrointestinal cancer diagnosis
Timeframe: Baseline